Andreas’ PhD research focussed on elucidating the regulation of methane and multi-carbon metabolism in the facultative methane-oxidizing bacterium Methylocella silvestris BL2. Andreas’ research resulted in the authoring of several scientific publications and culminated in the sequencing of the M. silvestris genome by the US Department of Energy Joint Genome Institute.
Andreas' technical expertise underpins his work in the biotechnology and pharmaceutical fields, with particular emphasis on technologies including cellular expression systems, oligonucleotide, protein and peptide-based therapeutics, recombinant vaccines, diagnostic and therapeutic antibodies, diagnostic assays for diseases, gene therapy and medical devices.
His practice areas include drafting and prosecution of global patent families and freedom-to-operate advice. Andreas has experience working "in house" on secondment to a UK biotechnology client, and has experience in EPO Oppositions and Appeals.
He also holds a Certificate in Intellectual Property Law from London University, and is a native German speaker.